Literature DB >> 10537167

Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine.

L Hansen1, C F Deacon, C Orskov, J J Holst.   

Abstract

The insulinotropic hormone glucagon-like peptide-1 (GLP-1) is stored in the intestinal L cell in an active form, GLP-1-(7-36)amide, but more than half of the endogenous peptide circulates in an inactive, N-terminally truncated form, GLP-1-(9-36)amide. This study examined the GLP-1 newly secreted from the porcine ileum, in vitro (isolated perfused preparation) and in vivo (anesthetized pig), to determine where this conversion occurs. Although the GLP-1 extractable from the porcine ileum is predominantly the intact peptide (94.6+/-1.7%), a large proportion of the GLP-1 that is secreted has already been degraded to the truncated form both in vitro (53.8+/-0.9% intact) and in vivo (32.9+/-10.8% intact). In the presence of a specific dipeptidyl peptidase IV (DPP IV) inhibitor (valine-pyrrolidide), the proportion of intact GLP-1 released from the perfused ileum was increased under both basal (99% intact; P < 0.05) and stimulated (86-101% intact; P < 0.05) conditions. Immunohistochemical and histochemical studies revealed specific DPP IV staining in the brush border epithelium as well as in the capillary endothelium. Double staining showed juxtapositioning of DPP IV-positive capillaries and GLP-1-containing L cells. From these results, we suggest that GLP-1 is degraded as it enters the DPP IV containing blood vessels draining the intestinal mucosa.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10537167     DOI: 10.1210/endo.140.11.7143

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  149 in total

1.  Co-expression of the homologous proteases fibroblast activation protein and dipeptidyl peptidase-IV in the adult human Langerhans islets.

Authors:  Petr Busek; Petr Hrabal; Premysl Fric; Aleksi Sedo
Journal:  Histochem Cell Biol       Date:  2014-11-02       Impact factor: 4.304

Review 2.  The structure and function of the glucagon-like peptide-1 receptor and its ligands.

Authors:  Dan Donnelly
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

3.  Association with nitric oxide synthase on insulin secretory granules regulates glucokinase protein levels.

Authors:  Michele L Markwardt; Andongfac Nkobena; Shi-Ying Ding; Mark A Rizzo
Journal:  Mol Endocrinol       Date:  2012-07-06

Review 4.  Whey protein: The "whey" forward for treatment of type 2 diabetes?

Authors:  Linda E Mignone; Tongzhi Wu; Michael Horowitz; Christopher K Rayner
Journal:  World J Diabetes       Date:  2015-10-25

Review 5.  G protein-coupled receptors as targets for anti-diabetic therapeutics.

Authors:  Da Young Oh; Jerrold M Olefsky
Journal:  Nat Rev Drug Discov       Date:  2016-01-29       Impact factor: 84.694

Review 6.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

Review 7.  Intestinal GLP-1 and satiation: from man to rodents and back.

Authors:  R E Steinert; C Beglinger; W Langhans
Journal:  Int J Obes (Lond)       Date:  2015-08-28       Impact factor: 5.095

8.  GLP-1 released to the mesenteric lymph duct in mice: effects of glucose and fat.

Authors:  Lena Ohlsson; Alison B Kohan; Patrick Tso; Bo Ahrén
Journal:  Regul Pept       Date:  2014-02-28

Review 9.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

10.  Insulin-like actions of glucagon-like peptide-1: a dual receptor hypothesis.

Authors:  Eva Tomas; Joel F Habener
Journal:  Trends Endocrinol Metab       Date:  2009-12-16       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.